Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)

ClinicalTrials.gov ID: NCT03093701

Public ClinicalTrials.gov record NCT03093701. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 12:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Randomized, double-masked trial designed to investigate the use of TLC399 (ProDex) in subjects with macular edema due to CRVO or BRVO.

Study identification

NCT ID
NCT03093701
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Taiwan Liposome Company
Industry
Enrollment
31 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2017 (Actual)
Primary completion
Feb 4, 2019 (Actual)
Completion
Feb 4, 2019 (Actual)
Last update posted
Dec 23, 2021

2017 – 2019

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
Retinal Research Institute Phoenix Arizona 85014 —
Retina Institute of California Arcadia California 91007 —
Retina-Vitreous Associates Medical Group Beverly Hills California 90211 —
Retina Institute of California Palm Desert California 92260 —
Colorado Retina Associates Golden Colorado 80401 —
Retina Group of New England New London Connecticut 09320 —
Retina Macula Specialists of Miami Miami Florida 33126 —
Georgia Retina, P.C Marietta Georgia 30060 —
Ophthalmic Consultants of Boston Boston Massachusetts 02114 —
Retina Consultants of Nevada Las Vegas Nevada 89149 —
Retina Associates of Western New York, PC Rochester New York 14620 —
Charlotte Eye Ear Nose & Throat Assoc, PA Charlotte North Carolina 28210 —
The Cleveland Clinic Cleveland Ohio 44915 —
Retina Research Institute of Texas Abilene Texas 79606 —
Retina Research Center Austin Texas 78705 —
Retina Consultants of Houston Houston Texas 77030 —
Medical Center Ophthalmology Associates San Antonio Texas 78240 —
Retinal Consultants of San Antonio San Antonio Texas 78240 —
Retina Consultants of Houston,The Woodlands The Woodlands Texas 77384 —
University of Virginia Charlottesville Virginia 22903 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03093701, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 23, 2021 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03093701 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →